Literature DB >> 22311101

Synthesis and evaluation of triazole-linked poly(ε-caprolactone)-graft-poly(2-methyl-2-oxazoline) copolymers as potential drug carriers.

Brieuc Guillerm1, Vincent Darcos, Vincent Lapinte, Sophie Monge, Jean Coudane, Jean-Jacques Robin.   

Abstract

Well-defined graft copolymers were obtained using a copper-catalysed azide-alkyne Huisgen's cycloaddition click reaction from both biocompatible and non-toxic poly(ε-caprolactone) and poly(2-methyl-2-oxazoline) homopolymers. Resulting amphiphilic copolymers proved to form micelles that could be used as potential drug carriers.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22311101     DOI： 10.1039/c2cc30191a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  4 in total

1.  Evaluation of poly(2-ethyl-2-oxazoline) containing copolymer networks of varied composition as sustained metoprolol tartrate delivery systems.

Authors:  Bistra Kostova; Sijka Ivanova; Konstantin Balashev; Dimitar Rachev; Darinka Christova
Journal:  AAPS PharmSciTech       Date:  2014-05-03       Impact factor: 3.246

Review 2.  PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.

Authors:  Violet V Sheffey; Emily B Siew; Eden E L Tanner; Omolola Eniola-Adefeso
Journal:  Adv Healthc Mater       Date:  2022-01-27       Impact factor: 11.092

Review 3.  Poly(2-oxazoline)s as polymer therapeutics.

Authors:  Robert Luxenhofer; Yingchao Han; Anita Schulz; Jing Tong; Zhijian He; Alexander V Kabanov; Rainer Jordan
Journal:  Macromol Rapid Commun       Date:  2012-08-03       Impact factor: 5.734

4.  Thermoresponsive Molecular Brushes with a Rigid-Chain Aromatic Polyester Backbone and Poly-2-alkyl-2-oxazoline Side Chains.

Authors:  Elena Tarabukina; Emil Fatullaev; Anna Krasova; Maria Sokolova; Mikhail Kurlykin; Igor Neelov; Andrey Tenkovtsev; Alexander Filippov
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.